Glutathione S-transferase M1 and T1 status and the risk of laryngeal cancer: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2221-2226

  Kumar, Vinod ^a   Krishna Murthy, A ^b   Suresh, K P ^c  

^a M S RAMAIAH UNIVERSITY OF APPLIED SCIENCES   (India)

^b Ambedkar Dental College   (India)

^c ICAR NATIONAL INSTITUTE OF ANIMAL NUTRITION AND PHYSIOLOGY   (India)

Author keywords

GSTM1; GSTT1; Laryngeal cancer; Meta analysis; Polymorphism; Risk

Indexed keywords

GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ARTICLE; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; LARYNX TUMOR; META ANALYSIS; RISK; RISK FACTOR;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LARYNGEAL NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; RISK FACTORS;

EID: 84866277031     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Acar H, Ozturk K, Muslumanoglu MH, et al (2006). Relation of glutathione S-transferase genotypes (GSTM1 and GSTT1) to laryngeal squamous cell carcinoma risk. Cancer Genet Cytogenet, 169, 89-93.
2. Bardakci F, Canbay E, Degerli N, Coban L, Canbay EI (2003). Relationship of tobacco smoking with GSTM1 gene polymorphism in laryngeal cancer. J Cell Mol Med, 7, 307-12.
3. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
4. Biselli JM, de Angelo Calsaverini Leal RC, Ruiz MT, et al (2006). GSTT1 and GSTM1 polymorphism in cigarette smokers with head and neck squamous cell carcinoma. Rev Bras Otorrinolaringol, 72, 654-8.
5. Chen K, Jiang QT, He HQ (2005). Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol, 11, 331-5.
6. Cooper HM, Hedges LV (1994). The Handbook of Research Synthesis. Vol 236, New York; Russell Sage Foundation.
7. Coutelle C, Ward PJ, Fleury B, et al (1997). Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum Genet, 99, 319-25.
8. Dipple A, Lawley PD, Brookes P (1968). Theory of tumour initiation by chemical carcinogens: dependence of activity on structure of ultimate carcinogen. Eur J Cancer, 4, 493-506.
9. Dipple A (1995). DNA adducts of chemical carcinogens. Carcinogenesis, 16, 437-1.
10. Egger M, Davey SG, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
11. Gajecka M, Rydzanicz M, Jaskula-Sztul R, et al (2005). CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res, 574, 112-23.
12. Glass GV (1976). Primary, secondary and meta-analysis of research. Education research, 5, 3-8.
13. Gattás GJF, de Carvalho MB, Siraque MS, et al (2006). Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck, 28, 819-26.
14. Geisler SA, Olshan AF (2001). GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: A Mini-HuGE review. Am J Epidemiol, 154, 95-105.
15. GLOBOCAN (2008). International Agency for Research on Cancer (Online) Available at: http://globocan.iarc.fr/factsheets/populations/factsheet. Accessed on 28th May 2011.
16. Goloni-Bertollo EM, Biselli JM, de Lima Corrêa LC et al. (2006). Evaluation of the influence of GSTT1 and GSTM1 null genotypes in head and neck carcinogenesis. Rev Assoc Med Bras, 52, 365-8.
17. Gronau S, Koenig-Greger D, Jerg M, Riechelmann H (2003). Gene polymorphisms in detoxiWcation enzymes as susceptibility factor for head and neck cancer? Otolaryngol Head Neck Surg, 128, 674-80.
18. Hanna E, MacLeod S, Vural E, Lang N (2001). Genetic deletions of glutathione-S-transferase as a risk factor in squamous cell carcinoma of the larynx: a preliminary report. Am J Otolaryngol, 22, 121-3.
19. Hashibe M, Brennan P, Strange RC, et al (2003). Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev, 12, 1509-17.
20. Hayes JD, Flanagan JU, Jowsey IR (2005). Glutathione transferases. Annu. Rev. Pharmacol. Toxicol, 45, 51-88.
21. Hong YJ, Lee JK, Lee GH, Hong SI (2000). Influence of glutathione S-transferase M1 and T1 genotypes on larynx cancer risk among Korean smokers. Clin Chem Lab Med, 38, 917-9.
22. Hosgood HD, Berndt SI, Lan Q (2007). GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-analysis. Mutat Res, 636, 134-43.
23. Jahnke V, Matthias C, Fryer A, Strange R (1996). Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Am J Surg, 172, 671-73.
24. Jaskula-Sztul R, Reinikainen M, Husgafvel-Pursiainen K, et al (1998). Glutathione S transferase M1 andT1 genotypes and susceptibility to smoking related larynx cancer. Biomarkers, 3, 149-55.
25. Jourenkova N, Reinikainen M, Bouchardy C, et al (1998). Larynx cancer risk in relation to glutathione S-transferase Ml and T1genotypes and tobacco smoking. Cancer Epidemiol Biomarkers Prev, 7, 19-23.
26. Ladner JE, Parsons JF, Rife CL, Gilliland GL, Armstrong RN (2004). Parallel evolutionary pathways for glutathione transferases:structure and mechanism of the mitochondrial class Kappa enzyme rGSTK1-1. Biochemistry, 43, 352-61.
27. Lai R, Crevier L, Thabane L (2005). Genetic polymorphisms of glutathione S-transferases and the risk of adult braintumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 14, 1784-90.
28. La Torre G, Boccia S, Ricciardi G (2005). Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett, 217, 53-60.
29. Li L, Lin P, Deng YF, Zhu ZL, Lu HH (2004). Relationship between susceptibility and prognosis of laryngeal cancer and genetic polymorphisms in CYP1A1 and GSTM1. Zhonghua Er Bi Yan Hou Ke Za Zhi, 39, 2-7.
30. Matthias C, Bockmühl U, Jahnke V et al (1998). Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics, 8, 91-100.
31. Miller EC, Miller JA (1966). Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules. Pharm. Rev, 18, 805-38.
32. Miller JA, Miller EC (1971). Chemical carcinogenesis: mechanism and approaches to its control. J Natl Cancer Inst, 47, V-XIV.
33. Morita S, Yano M, Tsujinaka T et al (1999). Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer, 80, 685-8.
34. Ntais C, Polycarpou A, Ioannidis JP (2005). Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 14, 176-81.
35. Peters ES, McClean MD, Marsit CJ, Luckett B, Kelsey KT (2006). Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 2196-202.
36. Phillips DH (2007). The Formation of DNA Adducts. In, Malcolm R. Alison (editor). The Cancer Handbook, 2nd Ed. John Wiley & Sons, Ltd, 293-305.
37. Risch A, Ramroth H, Raedts V et al (2003). Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modiWed by genetic polymorphisms in class I alcohol dehydrogenases ADH1B and ADH1C, and glutathione-S-transferases GSTM1 and GSTT1. Pharmacogenetics, 13, 225-30.
38. Saadat M (2006). Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci, 97, 505-9.
39. Tripathy CB, Roy N (2006). Meta-analysis of glutathione s-transferase M1genotype and risk toward head and neck cancer. Head Neck, 28, 217-24.
40. To-Figueras J, Gené M, Gómez-Catalán J et al (2002). Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk. Cancer Lett, 187, 95-101.
41. Unal M, Tamer L, Ateo NA et al (2004). Glutathione S-transferase M1, T1, and P1 gene polymorphism in laryngeal squamous cell carcinoma. Am J Otolaryngol, 25, 318-22.
42. Varela-Lema L, Taioli E, Ruano-Ravina A et al (2008). Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med, 10, 000-000.
43. Vogl FD, Taioli E, Maugard C et al (2004). Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev, 13, 1473-9.
44. White DL, Li D, Nurgalieva Z, El-Serag HB (2008). Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and metaanalysis. Am J Epidemiol, 167, 377-89.
45. Yang CX, Matsuo K, Wang ZM, Tajima K (2005). Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J Gastroenterol, 11, 2531-8.
46. Ye Z, Song H (2005). Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer, 41, 980-9.
47. Zhuo W, Wang Y, Zhuo X et al (2009). Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses. J Cancer Res Clin Oncol, 135, 1081-90.